Institute for Epidemiology, Social Medicine and Health Systems, Hannover Medical School, Hannover, Germany.
Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Infection. 2024 Oct;52(5):1775-1786. doi: 10.1007/s15010-024-02206-z. Epub 2024 Mar 23.
Epidemiological TB data indicate differences in infection prevalence, progression rates, and clinical disease incidence between sexes. In contrast, evidence on sex-specific differential (post) TB case fatality in Europe has not been synthesized systematically.
We searched electronic databases and grey literature up to December 2020 for studies reporting sex-stratified TB death data for Europe. The JBI critical appraisal tools served for bias risk assessment and subgroup analyses for studying heterogeneity. Random-effects models meta-analyses enabled estimating pooled relative risks of sex-associated TB fatality. Considering associations of comorbidities and risk factors on fatality differences, we applied relative risk meta-regression.
Based on 17,400 records screened, 117 studies entered quantitative analyses. Seventy-five studies providing absolute participant data with moderate quality and limited sex stratification reported 33 to 235,000 TB cases and 7 to 27,108 deaths. The pooled male-to-female TB fatality risk ratio was 1.4 [1.3-1.5]. Heterogeneity was high between studies and subgroups. Study time, concurrent comorbidities (e.g., HIV, diabetes, cancers), and mean participant ages showed no effect modification. We identified higher male TB fatality in studies with higher homelessness (coefficient 3.18, 95% CI [-0.59 to 6.94], p-value 0.10) and lower migrants proportion (coefficient - 0.24, 95% CI [- 0.5 to 0.04], p-value 0.09).
We found 30-50% higher TB case fatality for males in Europe. Except for homelessness, migration, and a trend for some comorbidities, assessing effect modification could not reduce our meta-analysis' high heterogeneity. Public health authorities should take heed of this higher risk of dying in male patients' treatment services.
流行病学结核病数据表明,性别之间的感染流行率、进展率和临床疾病发病率存在差异。相比之下,欧洲关于性别特异性差异(后)结核病病死率的证据尚未得到系统综合。
我们检索了电子数据库和灰色文献,以获取截至 2020 年 12 月报告欧洲性别分层结核病死亡数据的研究。JBI 批判性评估工具用于评估偏倚风险,并进行亚组分析以研究异质性。随机效应模型荟萃分析使我们能够估计性别相关结核病病死率的汇总相对风险。考虑到合并症和危险因素对病死率差异的影响,我们应用了相对风险荟萃回归。
根据筛选出的 17400 条记录,有 117 项研究进入了定量分析。75 项提供了具有中等质量和有限性别分层的绝对参与者数据的研究报告了 33 至 235000 例结核病病例和 7 至 27108 例死亡。汇总的男性与女性结核病病死率风险比为 1.4 [1.3-1.5]。研究之间和亚组之间存在高度异质性。研究时间、并发合并症(如 HIV、糖尿病、癌症)和平均参与者年龄均未显示出效应修饰。我们发现,在报告无家可归率较高(系数 3.18,95%CI[-0.59 至 6.94],p 值 0.10)和移民比例较低(系数-0.24,95%CI[-0.5 至 0.04],p 值 0.09)的研究中,男性结核病病死率更高。
我们发现欧洲男性结核病病死率高 30-50%。除无家可归、移民以及一些合并症的趋势外,评估效应修饰并不能降低我们荟萃分析的高度异质性。公共卫生当局应注意到男性患者在治疗服务中死亡风险较高。